Spero Therapeutics Stock Forecast - Day Median Price
| SPRO Stock | USD 1.13 0.02 1.74% |
Spero Stock Forecast is based on your current time horizon. Although Spero Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Spero Therapeutics' systematic risk associated with finding meaningful patterns of Spero Therapeutics fundamentals over time.
Spero |
| Previous Day Median Price | Day Median Price | Trend |
| 1.14 | 1.14 |
| Check Spero Therapeutics Volatility | Backtest Spero Therapeutics | Information Ratio |
Spero Therapeutics Trading Date Momentum
| On November 27 2024 Spero Therapeutics was traded for 1.13 at the closing time. The top price for the day was 1.17 and the lowest listed price was 1.10 . There was no trading activity during the period 0.0. Lack of trading volume on November 27, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 2.65% . |
The median price is the midpoint of the trading periods range.
| Compare Spero Therapeutics to competition |
Other Forecasting Options for Spero Therapeutics
For every potential investor in Spero, whether a beginner or expert, Spero Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Spero Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Spero. Basic forecasting techniques help filter out the noise by identifying Spero Therapeutics' price trends.Spero Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spero Therapeutics stock to make a market-neutral strategy. Peer analysis of Spero Therapeutics could also be used in its relative valuation, which is a method of valuing Spero Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Spero Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Spero Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Spero Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Spero Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Spero Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spero Therapeutics shares will generate the highest return on investment. By undertsting and applying Spero Therapeutics stock market strength indicators, traders can identify Spero Therapeutics entry and exit signals to maximize returns.
Spero Therapeutics Risk Indicators
The analysis of Spero Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Spero Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting spero stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.78 | |||
| Standard Deviation | 2.49 | |||
| Variance | 6.21 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Spero Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spero Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Spero Stock
| 0.68 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.66 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Spero Stock
| 0.69 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.48 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.42 | ESLAW | Estrella Immunopharma | PairCorr |
| 0.37 | MNOV | MediciNova | PairCorr |
| 0.34 | PHVS | Pharvaris BV | PairCorr |
The ability to find closely correlated positions to Spero Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spero Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spero Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spero Therapeutics to buy it.
The correlation of Spero Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spero Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Spero Therapeutics to cross-verify your projections. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share 0.08 | Revenue Per Share 2.223 | Quarterly Revenue Growth 2.754 | Return On Assets 0.1048 |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.